Comparison of detection methods and follow-up study on the tyrosine kinase inhibitors therapy in non-small cell lung cancer patients with ROS1 fusion rearrangement

BACKGROUND: The screening of ROS proto-oncogene 1, receptor tyrosine kinase(ROS1) fusion rearrangement might be potentially beneficial for an effective therapy against non-small cell lung cancer (NSCLC). However, the three main ROS1 rearrangement detection methods have limitations, and no routine pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jieyu, Lin, Yunen, He, Xinming, Yang, Haihong, He, Ping, Fu, Xinge, Li, Guangqiu, Gu, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973062/
https://www.ncbi.nlm.nih.gov/pubmed/27488371
http://dx.doi.org/10.1186/s12885-016-2582-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973062/
https://www.ncbi.nlm.nih.gov/pubmed/27488371
http://dx.doi.org/10.1186/s12885-016-2582-9

Ejemplares similares